Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Patients worry that pharma taints doctors' decisions
Fierce Pharma
Wednesday, August 25, 2010 - 12:18pm
tags:
patients, physicians, physican gifts
[video] They Just Don't Get Pfizer!
TheStreet.com
Wednesday, August 25, 2010 - 12:16pm
tags:
Pfizer
Insulin Users Have 50% Higher Cancer Risk; Causes Are Unclear, Study Says
Bloomberg
Wednesday, August 25, 2010 - 12:15pm
tags:
diabetes, insulin, cancer, Lantus, Sanofi
Elan Defends Alzheimer’s Science
Forbes
Wednesday, August 25, 2010 - 12:12pm
tags:
Elan, Alzheimer's disease, Eli Lilly
Takeda's Actos Has Same Heart Risks as Glaxo's Avandia, Researchers Find
Bloomberg
Wednesday, August 25, 2010 - 7:53am
tags:
diabetes, Takeda, Actos, GSK, Avandia
Stem Cell Competition Heating Up
Seeking Alpha
Wednesday, August 25, 2010 - 7:51am
tags:
stem cells, Aastrom, Athersys, Celgene, Neurostem, Cytori, Geron, Opexa, Osiris, Pluristem, StemCells
Eisai reports upbeat results from PhIII epilepsy study
Fierce Biotech
Tuesday, August 24, 2010 - 6:13pm
tags:
Eisai, clinical trials, epilepsy
Pro Picks In Big Pharma Paying Big Dividends
Yahoo/IndieResearch
Tuesday, August 24, 2010 - 6:07pm
tags:
dividends, Abbott Laboratories, Pfizer, GSK, Eli Lilly, Merck
One Day, the J&J Recalls Will End
Motley Fool
Tuesday, August 24, 2010 - 6:04pm
tags:
recalls, JNJ
Pfizer Failure Clears Way for Small Biotech ArQule
Minyanville
Tuesday, August 24, 2010 - 1:48pm
tags:
Pfizer, Sutent, Arqule, small cell lung cancer
Could Amgen Be a Multibagger?
Motley Fool
Tuesday, August 24, 2010 - 1:09pm
tags:
Amgen
Will Valeant Pharmaceuticals Burn You?
Motley Fool
Tuesday, August 24, 2010 - 1:07pm
tags:
Valeant Pharmaceuticals
WHO gives Pfizer vaccine nod for int'l procurement
Bloomberg Businessweek
Tuesday, August 24, 2010 - 12:09pm
tags:
WHO, Pfizer, vaccines, Prevnar 13
Stem-cell researchers slide on court ruling
Marketwatch
Tuesday, August 24, 2010 - 11:41am
tags:
stem cells, Geron, StemCells, Aastrom, Cytori, Athersys
AVI Biopharma reports positive swine flu drug test results
Bizjournals.com
Tuesday, August 24, 2010 - 11:39am
tags:
swine flu, AVI BioPharma, Alexion
Recall fallout: FDA puts execs on notice
CNN Money
Tuesday, August 24, 2010 - 11:38am
tags:
recalls, FDA, pharmaceutical executives
HPV Vaccine Rate Rises Among Teenage Girls
Pharmalot
Tuesday, August 24, 2010 - 10:35am
tags:
HPV, vaccines, Gardasil, Merck, GSK, Cervarix
Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
Yahoo
Tuesday, August 24, 2010 - 10:32am
tags:
Warner Chilcott, generics, FDA
Merck foundation adds to Botswana partnership
Yahoo/AP
Tuesday, August 24, 2010 - 10:31am
tags:
Merck, Africa, AIDS, HIV
Novo Nordisk To Test Victoza In Anti-Obesity - CEO
WSJ Online
Tuesday, August 24, 2010 - 8:01am
tags:
obesity, Novo Nordisk, Victoza

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.